Form 4 for ZNTL Zentalis Pharmaceuticals, Inc.
Accepted 2024-05-31 00:00:00 ET · period of report 2024-05-31 · accession 0001725160-24-000127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-31 | 2024-05-31 | ZNTL | Gallagher Cam | Pres, Interim CFO, Dir | S - Sale | $11.98 | -9,597 | 633.7K | -1% | -$115.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-31 | S | D | 9,597 | $11.98 | 633,680 | D | — | — |